Mosedipimod
Mosedipimod is a monoacetyldiaglyceride that can be isolated from Cervus nippon Temminck. Mosedipimod is an orally active Toll-Like Receptor signaling inhibitor. Mosedipimod attenuates airway infammation by reducing myeloperoxidase expression in lung tissue. Mosedipimod is used in chronic obstructive pulmonary disease research[1].
Product Specifications
CAS Number
[221139-79-3]
Product Name Alternative
EC-18
UNSPSC
12352211
Target
Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mosedipimod.html
Solubility
10 mM in DMSO
Smiles
O=C(CCCCCCC/C=C\C/C=C\CCCCC)OC(COC(C)=O)COC(CCCCCCCCCCCCCCC)=O
Molecular Formula
C39H70O6
Molecular Weight
634.97
References & Citations
[1]Shin IS, et al. Protective effect of EC-18, a synthetic monoacetyldiglyceride on lung inflammation in a murine model induced by cigarette smoke and lipopolysaccharide. Int Immunopharmacol. 2016 Jan;30:62-68.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1032654-01 0.02 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Iron-sulfur flavoprotein AF_1896 (AF_1896)
Ask
View Details MBS1032654-02 0.1 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Iron-sulfur flavoprotein AF_1896 (AF_1896)
Ask
View Details 
MBS1032654-03 0.02 mg (Yeast)
Recombinant Archaeoglobus fulgidus Iron-sulfur flavoprotein AF_1896 (AF_1896)
Ask
View Details 
MBS1032654-04 0.1 mg (Yeast)
Recombinant Archaeoglobus fulgidus Iron-sulfur flavoprotein AF_1896 (AF_1896)
Ask
View Details